Literature DB >> 25893736

A carbazole alkaloid deactivates mTOR through the suppression of rictor and that induces apoptosis in lung cancer cells.

Priyajit Chatterjee1, Soma Seal, Sandip Mukherjee, Rakesh Kundu, Mantu Bhuyan, Nabin C Barua, Pranab K Baruah, Santi Prasad Sinha Babu, Samir Bhattacharya.   

Abstract

Non-small cell lung cancer (NSCLC) is known to be a difficult cancer to treat because of its poor prognosis, limited option for surgery, and resistance to chemo or radiotherapy. In this study, we have demonstrated that suppression of rictor expression in A549 and H1299 NSCLC cells by mahanine, a carbazole alkaloid, disrupted constitutive activation of mTOR and Akt. Mahanine suppression of rictor gene expression and consequent attenuation of its protein expression affected the inhibition of mTOR (Ser-2481) and Akt (Ser-473) phosphorylation. Since mahanine treatment revealed this new insight of rictor-mTOR relationship, we examined an association between mTOR activation with rictor expression. Interestingly, in rictor knockdown (KD) NSCLC cells, mTOR activation was significantly impaired. Transfection of rictor over-expression vector into the NSCLC cells reversed this situation. In fact, both rictor KD and mahanine treated cells showed considerably depleted phospho-mTOR level. These results indicate that rictor is required to maintain constitutive activation of mTOR in lung cancer cells. When mTOR kinase activity in rictor KD cells was examined with Akt as substrate, a significant reduction of Akt phosphorylation indicated impairment of mTOR kinase potentiality. Disruption of mTOR and Akt activation caused drastic mortality of NSCLC cancer cells through apoptosis. Hence, our study reveals a new dimension in mTOR-rictor relationship, where rictor stands to be a suitable therapeutic target for lung cancer.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25893736     DOI: 10.1007/s11010-015-2406-2

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  30 in total

1.  Akt/protein kinase B is constitutively active in non-small cell lung cancer cells and promotes cellular survival and resistance to chemotherapy and radiation.

Authors:  J Brognard; A S Clark; Y Ni; P A Dennis
Journal:  Cancer Res       Date:  2001-05-15       Impact factor: 12.701

2.  Bexarotene in combination with chemotherapy fails to prolong survival in patients with advanced non-small-cell lung cancer: results from the SPIRIT I and II trials.

Authors:  Preeta Tyagi
Journal:  Clin Lung Cancer       Date:  2005-07       Impact factor: 4.785

3.  Phosphorylated Akt overexpression and loss of PTEN expression in non-small cell lung cancer confers poor prognosis.

Authors:  Jian-Min Tang; Quan-Ying He; Rui-Xia Guo; Xiu-Jun Chang
Journal:  Lung Cancer       Date:  2006-02       Impact factor: 5.705

4.  Molecular characteristics of non-small cell lung cancer.

Authors:  M Nacht; T Dracheva; Y Gao; T Fujii; Y Chen; A Player; V Akmaev; B Cook; M Dufault; M Zhang; W Zhang; M Guo; J Curran; S Han; D Sidransky; K Buetow; S L Madden; J Jen
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-18       Impact factor: 11.205

5.  Overexpression of cyclin B1 in early-stage non-small cell lung cancer and its clinical implication.

Authors:  J C Soria; S J Jang; F R Khuri; K Hassan; D Liu; W K Hong; L Mao
Journal:  Cancer Res       Date:  2000-08-01       Impact factor: 12.701

6.  p53 gene mutations are associated with shortened survival in patients with advanced non-small cell lung cancer: an analysis of medically managed patients.

Authors:  I Murakami; K Hiyama; S Ishioka; M Yamakido; F Kasagi; Y Yokosaki
Journal:  Clin Cancer Res       Date:  2000-02       Impact factor: 12.531

7.  Frequent activation of AKT in non-small cell lung carcinomas and preneoplastic bronchial lesions.

Authors:  Binaifer R Balsara; Jianming Pei; Yasuhiro Mitsuuchi; Robert Page; Andres Klein-Szanto; Hao Wang; Michael Unger; Joseph R Testa
Journal:  Carcinogenesis       Date:  2004-07-07       Impact factor: 4.944

8.  FKBP51 affects cancer cell response to chemotherapy by negatively regulating Akt.

Authors:  Huadong Pei; Liang Li; Brooke L Fridley; Gregory D Jenkins; Krishna R Kalari; Wilma Lingle; Gloria Petersen; Zhenkun Lou; Liewei Wang
Journal:  Cancer Cell       Date:  2009-09-08       Impact factor: 31.743

9.  Adipocyte fetuin-A contributes to macrophage migration into adipose tissue and polarization of macrophages.

Authors:  Priyajit Chatterjee; Soma Seal; Sandip Mukherjee; Rakesh Kundu; Sutapa Mukherjee; Sukanta Ray; Satinath Mukhopadhyay; Subeer S Majumdar; Samir Bhattacharya
Journal:  J Biol Chem       Date:  2013-08-13       Impact factor: 5.157

10.  PTEN and phosphorylated AKT expression and prognosis in early- and late-stage non-small cell lung cancer.

Authors:  W T Lim; W H Zhang; C R Miller; J W Watters; F Gao; A Viswanathan; R Govindan; H L McLeod
Journal:  Oncol Rep       Date:  2007-04       Impact factor: 3.906

View more
  7 in total

1.  Increased Levels of Rictor Prevent Mutant Huntingtin-Induced Neuronal Degeneration.

Authors:  Jordi Creus-Muncunill; Laura Rué; Rafael Alcalá-Vida; Raquel Badillos-Rodríguez; Joan Romaní-Aumedes; Sonia Marco; Jordi Alberch; Isabel Perez-Otaño; Cristina Malagelada; Esther Pérez-Navarro
Journal:  Mol Neurobiol       Date:  2018-02-19       Impact factor: 5.590

2.  Targeting mTORC2 component rictor inhibits cell proliferation and promotes apoptosis in gastric cancer.

Authors:  Yu-Hai Bian; Jia Xu; Wen-Yi Zhao; Zi-Zhen Zhang; Lin Tu; Hui Cao; Zhi-Gang Zhang
Journal:  Am J Transl Res       Date:  2017-09-15       Impact factor: 4.060

3.  10-Gingerol as an inducer of apoptosis through HTR1A in cumulus cells: In-vitro and in-silico studies.

Authors:  Kiptiyah Kiptiyah; Widodo Widodo; Gatot Ciptadi; Aulanni'am Aulanni'am; Mohammad A Widodo; Sutiman B Sumitro
Journal:  J Taibah Univ Med Sci       Date:  2017-06-23

Review 4.  Medicinal Profile, Phytochemistry, and Pharmacological Activities of Murraya koenigii and its Primary Bioactive Compounds.

Authors:  Rengasamy Balakrishnan; Dhanraj Vijayraja; Song-Hee Jo; Palanivel Ganesan; In Su-Kim; Dong-Kug Choi
Journal:  Antioxidants (Basel)       Date:  2020-01-24

5.  Association of genetic variants in lncRNA GAS5/miR-21/mTOR axis with risk and prognosis of coronary artery disease among a Chinese population.

Authors:  Hu Li; Yingxue Liu; Jinyan Huang; Yu Liu; Yufeng Zhu
Journal:  J Clin Lab Anal       Date:  2020-06-17       Impact factor: 2.352

6.  Rictor Activates Cav 1 Through the Akt Signaling Pathway to Inhibit the Apoptosis of Gastric Cancer Cells.

Authors:  Rui-Zhen Cao; Li Min; Si Liu; Ru-Yue Tian; Hai-Yan Jiang; Juan Liu; Lin-Lin Shao; Rui Cheng; Sheng-Tao Zhu; Shui-Long Guo; Peng Li
Journal:  Front Oncol       Date:  2021-09-01       Impact factor: 6.244

7.  Feiyanning Formula Induces Apoptosis of Lung Adenocarcinoma Cells by Activating the Mitochondrial Pathway.

Authors:  Li-Min Zhu; Hai-Xia Shi; Masahiro Sugimoto; Kenjiro Bandow; Hiroshi Sakagami; Shigeru Amano; Hai-Bin Deng; Qing-Yu Ye; Yun Gai; Xiao-Li Xin; Zhen-Ye Xu
Journal:  Front Oncol       Date:  2021-07-02       Impact factor: 6.244

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.